Matthew Stanton
Stock Analyst at Jefferies
(0.19)
# 4,341
Out of 5,008 analysts
6
Total ratings
33.33%
Success rate
-38.22%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGEN Repligen | Maintains: Hold | $145 → $135 | $150.10 | -10.06% | 1 | Sep 12, 2025 | |
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $9.98 | -19.84% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.32 | +146.21% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $26.52 | -17.04% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $31.80 | +101.26% | 1 | Apr 4, 2024 |
Repligen
Sep 12, 2025
Maintains: Hold
Price Target: $145 → $135
Current: $150.10
Upside: -10.06%
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $9.98
Upside: -19.84%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.32
Upside: +146.21%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $26.52
Upside: -17.04%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $31.80
Upside: +101.26%